MAY 09, 2019 6:00 AM PDT

AI-Driven Literature Curation for Determining Genomic Variant Pathogenicity

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Co-Founder and Chief Science Officer, Genomenon
    Biography

      Dr. Mark Kiel is Co-Founder and Chief Science Officer at Genomenon, where he oversees the company's scientific direction and product development. After spending 15 years preparing for a life of academic research, Mark became convinced that revolutionary change in genomics was more likely to emerge out of industry. In 2014, he founded Genomenon - an A.I.-driven life science company addressing the challenge of connecting pharma researchers with evidence in the literature to help diagnose and treat patients with genetic diseases and cancer.


    Abstract

    Variant interpretation presents a bottleneck for many labs, posing a challenge to the broader adoption of precision medicine. The ACMG/AMP variant classification framework has provided a foundation for this process, but several key obstacles remain. In particular, the identification and prioritization of key publications presents a time- and resource-intensive challenge for many labs.

    In this presentation, Dr. Mark Kiel, CSO and Co-Founder of Genomenon will discuss challenges to automating variant interpretation while improving the accuracy and reproducibility of the process using Mastermind - the world's most comprehensive literature-based Genomic Search Engine. He will guide the viewer through examples of Mastermind users, including the Rare Genomics Institute who were able to change their patients' diagnoses using findings that were only identified through Mastermind.

    Learning Objectives: 

    1. How to more efficiently identify and prioritize publications by ACMG variant classification guidelines.
    2. How increased specificity and immediate access to annotated search results accelerates variant interpretation workflow.
    3. How increased sensitivity in literature search results in fewer false negatives.
     


    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    MAY 09, 2019 6:00 AM PDT

    AI-Driven Literature Curation for Determining Genomic Variant Pathogenicity

    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Biotechnology

    Cell Biology

    Immunology

    Cell Culture

    Bioinformatics

    Dna Sequencing

    Molecular Biology

    Cancer Research

    T-Cells

    Cancer

    Animal Research

    Cell

    Biomarkers

    Mass Cytometry

    Cancer Therapeutics

    Geography

    North America40%

    Europe40%

    Africa20%

    Registration Source

    Website Visitors100%

    Job Title

    Student50%

    Facility/Department Manager25%

    Research Scientist25%

    Organization

    Academic Institution60%

    Distribution/sales20%

    Government20%


    Show Resources
    Loading Comments...
    Show Resources